Search details
1.
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.
Diabetes Obes Metab
; 26(4): 1395-1406, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38287130
2.
Chemically synthesized LYRM03 could inhibit the metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
Bioorg Med Chem Lett
; 29(14): 1719-1726, 2019 07 15.
Article
in English
| MEDLINE | ID: mdl-31126854
3.
Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial.
Signal Transduct Target Ther
; 8(1): 20, 2023 01 03.
Article
in English
| MEDLINE | ID: mdl-36596779
4.
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial.
Signal Transduct Target Ther
; 7(1): 172, 2022 06 06.
Article
in English
| MEDLINE | ID: mdl-35665745
5.
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.
Nat Commun
; 13(1): 3654, 2022 06 27.
Article
in English
| MEDLINE | ID: mdl-35760812
6.
[Result of serology test for yellow fever virus (YFV) in the entry-exit persons in Guangzhou frontier port and the forecast of risk on YFV infection].
Zhonghua Liu Xing Bing Xue Za Zhi
; 33(5): 544-5, 2012 May.
Article
in Zh
| MEDLINE | ID: mdl-22993842
Results
1 -
6
de 6
1
Next >
>>